Sparrow Pharmaceuticals, Inc.

Amendment
CIK: 0001786949·Pharmaceuticals·DELAWARE·Filed: Jun 26, 2020
Total Offering

$337,500

Amount Sold

$337,500

Investors

10

First Sale

Aug 21, 2018

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
David Aaron Katz
Related Person

Company

Sparrow Pharmaceuticals, Inc.

920 SW 6th Ave

PORTLAND, OR, 97204

312-752-8446

SEC Filing

0001786949-20-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sparrow Pharmaceuticals, Inc. Form D Filing — $337,500 | FilingFlow